Leicester Cancer Research Center
Howard Pringle has not added Biography.
If you are Howard Pringle and would like to personalize this page please email our Author Liaison for assistance.
Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Cancer research Jun, 2002 | Pubmed ID: 12036947
Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
Oncogene Oct, 2002 | Pubmed ID: 12360407
Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.
Anticancer research Nov-Dec, 2002 | Pubmed ID: 12553024
High BRAF mutation frequency does not characterize all melanocytic tumor types.
International journal of cancer Sep, 2004 | Pubmed ID: 15252839
Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2006 | Pubmed ID: 16899595
Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Experimental cell research Jan, 2007 | Pubmed ID: 17141758
WNT5A expression increases during melanoma progression and correlates with outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2008 | Pubmed ID: 18794093
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
Breast cancer research : BCR , 2009 | Pubmed ID: 19405959
Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.
Breast cancer research : BCR , 2010 | Pubmed ID: 20678196
Expression of tenascin-C and its isoforms in the breast.
Cancer metastasis reviews Dec, 2010 | Pubmed ID: 20814719
Expression of CTGF and Cyr61 in colorectal cancer.
Journal of clinical pathology Jan, 2011 | Pubmed ID: 21081514
Prognostic tissue markers in melanoma.
Histopathology Apr, 2012 | Pubmed ID: 21880059
Accurate detection of copy number changes in DNA extracted from formalin-fixed, paraffin-embedded melanoma tissue using duplex ratio tests.
The Journal of molecular diagnostics : JMD Sep, 2013 | Pubmed ID: 23810241
Influence of plasma processing on recovery and analysis of circulating nucleic acids.
PloS one , 2013 | Pubmed ID: 24205045
Plasticity of melanoma and EMT-TF reprogramming.
Oncotarget Jan, 2014 | Pubmed ID: 24369126
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer.
Clinical chemistry Jul, 2015 | Pubmed ID: 25979954
Novel plasma microRNA biomarkers for the identification of colitis-associated carcinoma.
Lancet (London, England) Feb, 2015 | Pubmed ID: 26312900
microRNA-10b is a prognostic biomarker for melanoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Feb, 2016 | Pubmed ID: 26743475
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 01, 2017 | Pubmed ID: 27713424
Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.
Oncotarget Oct, 2017 | Pubmed ID: 29152076
Correction to: Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.
Breast cancer research : BCR 08, 2018 | Pubmed ID: 30068377
Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity.
Cell death & disease 08, 2018 | Pubmed ID: 30166531
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery.
British journal of cancer 03, 2020 | Pubmed ID: 31894140
Exploration of Matrix Effects in Laser Ablation Inductively Coupled Plasma Mass Spectrometry Imaging of Cisplatin-Treated Tumors.
Analytical chemistry 07, 2020 | Pubmed ID: 32545955
The Sensitivity and Specificity of Novel Primers for Detection of BRAFV600E Mutation.
Asian Pacific journal of cancer prevention : APJCP Nov, 2020 | Pubmed ID: 33247675
Development of a patient-derived explant model for prediction of drug responses in endometrial cancer.
Gynecologic oncology Feb, 2021 | Pubmed ID: 33309417
Evaluating and comparing immunostaining and computational methods for spatial profiling of drug response in patient-derived explants.
Laboratory investigation; a journal of technical methods and pathology Dec, 2020 | Pubmed ID: 33318618
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados